ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO0707

Kidney Failure in Cancer-Related Mortality in the United States: A CDC WONDER Population-Based Analysis, 1999-2024

Session Information

Category: Acute Kidney Injury

  • 101 AKI: Epidemiology, Risk Factors, and Prevention

Authors

  • Vijayarao, Sree Sindhu, University of Miami Miller School of Medicine, Miami, Florida, United States
  • Maqbool, Farkhanda, Bakhtawar Amin Medical and Dental College, Multan, Punjab, Pakistan
  • Patel, Divya, Gujarat Medical Education and Research Society, Gandhinagar, GJ, India
  • Kuraku, Dileep Raja, Vinnic'kij nacional'nij medicnij universitet imeni Mikoli Pirogova, Vinnytsia, Vinnytsia Oblast, Ukraine
  • Keshapogu, Nagarjuna, Vinnic'kij nacional'nij medicnij universitet imeni Mikoli Pirogova, Vinnytsia, Vinnytsia Oblast, Ukraine
  • Thiyagarajan, Ragav Vikraman, MAHSA University, Federal Territory of Kuala Lumpur, Malaysia
  • Attaluri, Durga Manaswini, Sri Aurobindo Institute of Medical Sciences, Indore, MP, India
  • Venkatesh, Karthik Kanna, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, PY, India
  • Narla, Sai Jahnu Sree Reddy, Paris Regional Medical Center, Paris, Texas, United States
  • Khan, Nabiha, Faisalabad Medical University, Faisalabad, Punjab, Pakistan
  • Younas, Kashf, Bakhtawar Amin Medical and Dental College, Multan, Punjab, Pakistan
  • Tekuru, Yogesh, Saint Louis University, St. Louis, Missouri, United States
  • Vemulapalli, Sai Charan, Our Lady of Fatima University, Valenzuela, NCR, Philippines
  • Kalluri, Hara Gopal, Saint Martinus University Faculty of Medicine, Willemstad, Curaçao
  • Maqbool, Tehmeena, Bakhtawar Amin Medical and Dental College, Multan, Punjab, Pakistan
Background

Renal failure and Malignant neoplasms are leading causes of premature death worldwide. Their coexistence worsens outcomes, yet population-level mortality trends remain underexplored. This study examines temporal disparities in U.S. mortality from 1999 to 2024.

Methods

We conducted a retrospective CDC WONDER analysis (1999–2024) using ICD-10 codes N17-N19 (Renal Failure) followed by C00-C97( Malignant Neoplasms). Age-adjusted mortality rates (AAMR) were stratified by sex, race, census region, and urbanization. Joinpoint regression calculated Annual Percent Change (APC) and Average Annual Percent Change (AAPC) with p<0.05.

Results

Overall mortality rate rose from 10.27 in 1999 to 12.03 in 2024 with 623,696 deaths. The rate increased non-significantly from 1999–2012 (APC: 0.54, 95% CI: -0.30–1.39), then non-significantly declined from 2012–2016 (APC: -6.91, 95% CI: -14.01–0.79), then significantly rise from 2016–2024 (APC: 4.53*, 95% CI: 2.93–6.15; p<0.001). Mortality was higher in males (15.73) than females (9.29) in 2024. The highest AAMR was among Black populations (18.99, 95% CI: 18.49–19.50), followed by Whites (11.54, 95% CI: 11.40–11.68). Rates peaked at age ≥85 years (100.34). The West had the highest rate (13.11, 95% CI: 12.81–13.40), followed by the South (12.55, 95% CI: 12.27–12.83). AAMR was highest in Non-Core areas (10.82 , 95% CI: 10.34–11.29), followed by Small Metro areas (9.34 , 95% CI: 8.96–9.72).

Conclusion

This study reveals critical research gaps in renal failure and malignant neoplasms mortality trends across age, race, and geography. Urgent, equity-focused prevention strategies are required to dismantle persistent disparities.